1. Sequence 1 Label: GP91phox CRISPRevolution mod-sgRNA, GMP-Like; Analytical HPLC; Bioburden (Aerobes, Yeast, Mold) - Method Suitability; Bioburden (Aerobes, Yeast, Mold) Test; Endotoxin - Method Suitability; Endotoxin Test; Custom QC Documents; S/H
2. Sequence 2 Label: MagT1 CRISPRevolution mod-sgRNA, GMP-Like; Analytical HPLC; Bioburden (Aerobes, Yeast, Mold) - Method Suitability; Bioburden (Aerobes, Yeast, Mold) Test; Endotoxin - Method Suitability; Endotoxin Test; Custom QC Documents; S/H
3. Sequence 3 Label: CGD CRISPRevolution mod-sgRNA, GMP-Like; Analytical HPLC; Bioburden (Aerobes, Yeast, Mold) - Method Suitability; Bioburden (Aerobes, Yeast, Mold) Test; Endotoxin - Method Suitability; Endotoxin Test; Custom QC Documents; S/H
4. Sequence 4 Label: SCID CRISPRevolution mod-sgRNA, GMP-Like; Analytical HPLC; Bioburden (Aerobes, Yeast, Mold) - Method Suitability; Bioburden (Aerobes, Yeast, Mold) Test; Endotoxin - Method Suitability; Endotoxin Test; Custom QC Documents; S/H
The statutory authority for this sole source requirement is 41 U.S.C. 1901(e)(2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-1981301_2) to Bevin Feutrier at [email protected] or to Ryan Richards at [email protected] by 8:00 am eastern standard time August 23, 2019. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.